Impact of long-term hormone replacement therapy on in vivo and in vitro markers of lipid oxidation

Free Radical Research

Volumn 38, Issue 2, 2004, Pages 129-137

  Rontu, Riikka ^a,b   Solakivi, Tiina ^b   Teisala, Klaus ^a   Lehtimäki, Terho ^a,b   Punnonen, Reijo ^a   Jokela, Hannu ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

8 iso PGF2 ; Hormone replacement therapy; LDL oxidation; Lipoproteins; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALKADIENE; APOLIPOPROTEIN A1; BIOCHEMICAL MARKER; COPPER; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANALYSIS OF VARIANCE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MEASUREMENT; MENOPAUSAL SYNDROME; OXIDATIVE STRESS; REVIEW; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

APOLIPOPROTEINS; BIOLOGICAL MARKERS; DINOPROST; DRUG THERAPY, COMBINATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEVONORGESTREL; LIPID PEROXIDATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; TIME FACTORS;

EID: 0842323799     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760310001641169     Document Type: Review

References (48)

1. Ross, R. (1993) "The pathogenesis of atherosclerosis: a perspective for the 1990s", Nature 362, 801-809.
2. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. and Witztum, J.L. (1989) "Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity", N. Engl. J. Med. 320, 915-924.
3. Witztum, J.L. and Steinberg, D. (1991) "Role of oxidized low density lipoprotein in atherogenesis", J. Clin. Investig. 88, 1785-1792.
4. Goldstein, J.L., Ho, Y.K., Basu, S.K. and Brown, M.S. (1979) "Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition", Proc. Natl Acad. Sci. USA 76, 333-337.
5. Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J.R., Insull, W., Jr, Rosenfeld, M.E., Schaffer, S.A., Schwartz, C.J., Wagner, W.D. and Wissler, R.W. (1994) "A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association", Arterioscler. Thromb. 14, 840-856.
6. Kannel, W.B. (1987) "Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study", Am. Heart J. 114, 413-419.
7. Castelli, W.P. (1984) "Epidemiology of coronary heart disease: the Framingham study", Am. J. Med. 76, 4-12.
8. Bush, T.L., Barrett-Connor, E., Cowan, L.D., Criqui, M.H., Wallace, R.B., Suchindran, C.M., Tyroler, H.A. and Rifkind, B.M. (1987) "Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study", Circulation 75, 1102-1109.
9. Lobo, R.A., Notelovitz, M., Bernstein, L., Khan, F.Y., Ross, R.K. and Paul, W.L. (1992) "Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen", Am. J. Obstet. Gynecol. 166, 1182-1188.
10. Farish, E., Rolton, H.A., Barnes, J.F. and Hart, D.M. (1991) "Lipoprotein (a) concentrations in postmenopausal women taking norethisterone", Br. Med. J 303, 694.
11. Grodstein, F., Manson, J.E., Colditz, G.A., Willett, W.C., Speizer, F.E. and Stampfer, M.J. (2000) "A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease", Ann. Intern. Med. 133, 933-941.
12. Stampfer, M.J. and Colditz, G.A. (1991) "Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence", Prev. Med. 20, 47-63.
13. McManus, J., McEneny, J., Young, I.S. and Thompson, W. (1996) "The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro", Maturitas 25, 125-131.
14. Maziere, C., Auclair, M., Ronveaux, M.F., Salmon, S., Santus, R. and Maziere, J.C. (1991) "Estrogens inhibit copper and cell-mediated modification of low density lipoprotein", Atherosclerosis 89, 175-182.
15. Rifici, V.A. and Khachadurian, A.K. (1992) "The inhibition of low-density lipoprotein oxidation by 17-beta estradiol", Metabolism 41, 1110-1114.
16. Sack, M.N., Rader, D.J. and Cannon, R.O. III. (1994) "Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women", Lancet 343, 269-270.
17. Herrington, D.M., Reboussin, D.M., Brosnihan, K.B., Sharp, P.C., Shumaker, S.A., Snyder, T.E., Furberg, C.D., Kowalchuk, G.J., Stuckey, T.D., Rogers, W.J., Givens, D.H. and Waters, D. (2000) "Effects of estrogen replacement on the progression of coronary-artery atherosclerosis", N. Engl. J. Med. 343, 522-529.
18. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. and Vittinghoff, E. (1998) "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group", J. Am. Med. Assoc. 280, 605-613.
19. Viscoli, C.M., Brass, L.M., Kernan, W.N., Sarrel, P.M., Suissa, S. and Horwitz, R.I. (2001) "A clinical trial of estrogen-replacement therapy after ischemic stroke", N. Engl. J. Med. 345, 1243-1249.
20. Mc Manus, J., Mc Eneny, J., Thompson, W. and Young, I.S. (1997) "The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women", Atherosclerosis 135, 73-81.
21. Koh, K.K., Mincemoyer, R., Bui, M.N., Csako, G., Pucino, F., Guetta, V., Waclawiw, M. and Cannon, R.O. III. (1997) "Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women", N. Engl. J. Med. 336, 683-690.
22. Guetta, V., Panza, J.A., Waclawiw, M.A. and Cannon, R.O. III (1995) "Effect of combined 17 beta-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women", Am. J. Cardiol. 75, 1274-1276.
23. Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F. and Roberts, L.J.I. (1990) "A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism", Proc. Natl Acad. Sci. USA 87, 9383-9387.
24. Morrow, J.D., Frei, B., Longmire, A.W., Caziano, J.M., Lynch, S.M., Shyr, Y., Strauss, W.E., Oates, J.A. and Roberts, L.J.I. (1995) "Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage", N. Engl. J. Med. 332, 1198-1203.
25. Nquven, T. and Warnig, R. (1989) "Improved method for separation of total HDL cholesterol and subclasses", Clin. Chem. 35, 1086.
26. Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) "Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin. Chem. 18, 499-502.
27. Leinonen, J., Rantalaiho, V., Solakivi, T., Koivula, T., Wirta, O., Pasternack, A., Alho, H. and Lehtimäki, T. (1998) "Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients", Clin. Chim. Acta 28, 163-174.
28. Grady, D., Herrington, D., Bittrier, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., Newby, L.K., Waters, D., Vittinghoff, E. and Wenger, N. (2002) "Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II)", J. Am. Med. Assoc. 288, 49-57.
29. Knopp, R.H. (1988) "Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime", Am. J. Obstet. Gynecol. 158, 1630-1643.
30. Wakatsuki, A. and Sagara, Y. (1996) "Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen", Maturitas 25, 35-44.
31. Austin, M.A., Hokanson, J.E. and Edwards, K.L. (1998) "Hypertriglyceridemia as a cardiovascular risk factor", Am. J. Cardiol. 81, 7B-12B.
32. Humphries, K.H. and Gill, S. (2003) "Risks and benefits of hormone replacement therapy: the evidence speaks", CMAJ 168, 1001-1010.
33. Schaefer, E.J., Lamon-Fava, S., Jenner, J.L., McNamara, J.R., Ordovas, J.M., Davis, C.E., Abolafia, J.M., Lippel, K. and Levy, R.I. (1994) "Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial", J. Am. Med. Assoc. 271, 999-1003.
34. Wakatsuki, A., Ikenoue, N. and Sagara, Y. (1998) "Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women", Maturitas 28, 229-234.
35. Mueck, A.O., Seeger, H. and Lippert, T.H. (1998) "Estradiol inhibits LDL oxidation: do the progestins medroxyprogesterone acetate and norethisterone acetate influence this effect?", Clin. Exp. Obstet. Gynecol. 25, 26-28.
36. Arteaga, E., Rojas, A., Villaseca, P., Bianchi, M., Arteaga, A. and Duran, D. (1998) "In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women". Menopause 5, 16-23.
37. Zhu, X., Bonet, B. and Knopp, R.H. (2000) "Estradiol 17 beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees", Atherosclerosis 148, 31-41.
38. Chahboun, S., Tallineau, C., Pontcharraud, R., Guettier, A. and Piriou, A. (1990) "Polyunsaturated fatty acid profiles and alpha-tocopherol levels in plasma and whole blood incubated with copper. Evidence of inhibition of lipoperoxidation in plasma by hemolysate", Biochim. Biophys. Acta 1042, 324-329.
39. Wen, Y., Doyle, M.C., Harrison, R.F. and Feely, J. (1997) "The effect of hormone replacement therapy on vitamin E status in postmenopausal women", Maturitas 26, 121-124.
40. Kuo, S.M., Stout, A., Wactawski-Wende, J. and Leppert, P.C. (2002) "Ascorbic acid status in postmenopausal women with hormone replacement therapy", Maturitas 41, 45-50.
41. Wakatsuki, A., Ikenoue, N. and Sagara, Y. (1997) "Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women", Obstet. Gynecol. 90, 22-25.
42. Mackness, M.I. and Durrington, P.N. (1995) "HDL, its enzymes and its potential to influence lipid peroxidation", Atherosclerosis 115, 243-253.
43. Koivu, T.A., Dastidar, P., Jokela, H., Nikkari, S.T., Jaakkola, O., Koivula, T., Punnonen, R. and Lehtimaki, T. (2001) "The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women", Atherosclerosis 157, 471-479.
44. Morrow, J.D., Awad, J.A., Boss, H.J., Blair, I.A. and Roberts, L.J.I. (1992) "Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids", Proc. Natl Acad. Sci. USA 89, 10721-10725.
45. 2α in vivo is not affected by cyclooxygenase inhibition", Adv. Prostaglandin Tromboxane Leukot. Res. 23, 233-236.
46. Turpeinen, A.M., Basu, S. and Mutanen, M. (1998) "A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans", Prostaglandins Leukot. Essent. Fatty Acids 59, 229-233.
47. Basu, S., Smedman, A. and Vessby, B. (2000) "Conjugated linoleic acid induces lipid peroxidation in humans", FEBS Lett. 468, 33-36.
48. Ke, R.W., Todd Pace, D. and Ahokas, R.A. (2003) "Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women", Fertil. Steril. 79, 1118-1122.